Protective effects of pLNCX-SOD gene transfection on hepatocyte injury induced by obstructive jaundice in rats

Hepatobiliary and Pancreatic Diseases International

Volumn 6, Issue 2, 2007, Pages 194-198

  Gong, Peng ^a   Wang, Zhong Yu ^a   Wang, Hong Jiang ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Hepatocyte; Obstructive jaundice; Retrovirus; Superoxide dismutase

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE DUCT LIGATION; CELL CULTURE; CELL LINE; CHOLESTASIS; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; IN VITRO STUDY; INCUBATION TIME; LIVER CELL; LIVER CELL DAMAGE; LIVER PROTECTION; MALE; NONHUMAN; OBSTRUCTIVE JAUNDICE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RAT; RISK REDUCTION; SPRAGUE DAWLEY RAT; VIRAL GENE DELIVERY SYSTEM; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL LINE; DISEASE MODELS, ANIMAL; FREE RADICAL SCAVENGERS; GENE THERAPY; HEPATOCYTES; JAUNDICE, OBSTRUCTIVE; MALE; PLASMIDS; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE; TRANSFECTION;

EID: 34047253976     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Poupon R, Chazouilleres O, Poupon RE. Chronic cholestatic diseases. J Hepatol 2000;32:129-140.
2. Nousia-Arvanitakis S, Fotoulaki M, Economou H, Xefteri M, Galli-Tsinopoulou A. Long-term prospective study of the effect of ursodeoxycholic acid on cystic fibrosis-related liver disease. J Clin Gastroenterol 2001;32:324-328.
3. Zhou PH, Yao LQ, Zhang YQ, Gao WD, He GJ, Xu MD, et al. Endoscopic biliary drainage for biliary obstruction. Hepatobiliary Pancreat Dis Int 2003;2:598-601.
4. Kim WR, Ludwig J, Lindor KD. Variant forms of cholestatic diseases involving small bile ducts in adults. Am J Gastroenterol 2000;95:1130-1138.
5. Guo YX, Li YH, Chen Y, Chen PY, Luo PF, Li Y, et al. Percutaneous transhepatic metal versus plastic biliary stent in treating malignant biliary obstruction: a multiple center investigation. Hepatobiliary Pancreat Dis Int 2003;2: 594-597.
6. Zhong Z, Froh M, Wheeler MD, Smutney O, Lehmann TG, Thurman RG. Viral gene delivery of superoxide dismutase attenuates experimental cholestasis-induced liver fibrosis in the rat. Gene Ther 2002;9:183-191.
7. Caglikulekci M, Pata C, Apa DD, Dirlik M, Tamer L, Yaylak F, et al. The effect of N-acetylcysteine (NAC) on liver and renal tissue inducible nitric oxide synthase (iNOS) and tissue lipid peroxidation in obstructive jaundice stimulated by lipopolysaccharide (LPS). Pharmacol Res 2004;49: 227-238.
8. Uslu A, Cayci M, Nart A, Karaca C, Zalluhoglu N, Gurkan A, et al. Renal failure in obstructive jaundice. Hepatogastroenterology 2005;52:52-54.
9. Pitiakoudis M, Mimidis K, Tsaroucha AK, Papadopoulos V, Karayiannakis A, Simopoulos C. Predictive value of risk factors in patients with obstructive jaundice. J Int Med Res 2004;32:633-638.
10. Vendemiale G, Grattagliano I, Lupo L, Memeo V, Altomare E. Hepatic oxidative alterations in patients with extra-hepatic cholestasis. Effect of surgical drainage. J Hepatol 2002;37:601-605.
11. Yorganci K, Baykal A, Kologlu M, Saribas Z, Hascelik G, Sayek I. Endotoxin challenge causes a proinflammatory state in obstructive jaundice. J Invest Surg 2004;17:119-126.
12. Papakostas C, Bezirtzoglou E, Pitiakoudis M, Polychronidis A, Simopoulos C. Endotoxinemia in the portal and the systemic circulation in obstructive jaundice. Clin Exp Med 2003;3:124-128.
13. Weglicki W, Quamme G, Tucker K, Haigney M, Resnick L. Potassium, magnesium, and electrolyte imbalance and complications in disease management. Clin Exp Hypertens 2005;27:95-112.
14. Lehmann TG, Wheeler MD, Schoonhoven R, Bunzendahl H, Samulski RJ, Thurman RG. Delivery of Cu/Zn-superoxide dismutase genes with a viral vector minimizes liver injury and improves survival after liver transplantation in the rat. Transplantation 2000;69:1051-1057.
15. Salem TA, El-Refaei MF, Badra GA. Study of antioxidant enzymes level and phagocytic activity in chronic liver disease patients. Egypt J Immunol 2003;l0:37-45.
16. Qureshi WA. Intrahepatic cholestatic syndromes: pathogenesis, clinical features and management. Dig Dis 1999;17:49-59.
17. Scott-Conner CE, Grogan JB. Serum and cellular factors in murine obstructive jaundice. Surgery 1994;115:77-84.
18. Paumgartner G, Beuers U. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. Hepatology 2002;36:525-531.
19. Zhong Z, Connor HD, Yin M, Wheeler MD, Mason RP, Thurman RG. Viral delivery of superoxide dismutase gene reduces cyclosporine A-induced nephrotoxicity. Kidney Int 2001;59:1397-1404.
20. Wheeler MD, Kono H, Yin M, Rusyn I, Froh M, Connor HD, et al. Delivery of the Cu/Zn-superoxide dismutase gene with adenovirus reduces early alcohol-induced liver injury in rats. Gastroenterology 2001;120:1241-1250.
21. Pastor A, Collado PS, Almar M, Gonzalez-Gallego J. Antioxidant enzyme status in biliary obstructed rats: effects of N-acetylcysteine. J Hepatol 1997;27:363-370.
22. Muriel P, Suarez OR. Role of lipid peroxidation in biliary obstruction in the rat. J Appl Toxicol 1994;14:423-426.